eClinical talks future of data management

By Alexandria Pešić and Claire Videau

- Last updated on GMT

Related tags: Data management, Clinical trial, Pharmacology, Pharmaceutical industry

eClinical talks future of data management
Clinical data management is, and will continue to be a key concern for the pharmaceutical industry, according to Susan Bornstein, executive vice president of eClinical solutions, who discussed the issue with Outsourcing-pharma earlier this week.

Although collecting and storing data is widely recognised as vital to ensuring both the quality and efficiency of a clinical trial, the cost and time-consuming nature of activity can pose a significant challenge for contract research organisations and pharma sponsors.

In this podcast, Bornstein explains how effective data management can help researchers overcome these problems and, with an eye on the recent economic downturn, suggests that the correct use of such techniques can help drug firms woo investment and development partners.

She also shares her views on how data management can move forward by providing access to “cleaner data, faster,” along with the ability to integrate results from multiple sources, while keeping the costs of clinical development to a minimum. This she says, will “ensure researchers are able to view the results of a clinical trial in the most effective way possible.”

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us


View more